Viridian Therapeutics, Inc. VRDN Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s interest income?
- Viridian Therapeutics, Inc. (VRDN) reported interest income of $7.87M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s interest income changed year-over-year?
- Viridian Therapeutics, Inc.'s interest income increased by 4.4% year-over-year, from $7.54M to $7.87M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s interest income has grown at a 204.7% compound annual growth rate (CAGR), from $318K to $27.4M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.